My lab develops an early detection assay for ovarian cancer and studies mechanisms of resistance to chemotherapy in order to develop strategies for tailor-made first line therapy and improve cure. All our projects are collaborative and involve human samples, close contact to the clinic and bioinformatics.
Education:
2006-2009, Post-doctoral fellowship at Dana Farber Cancer Institute, Harvard Medical School, Boston, USA
1999-2003, PhD, Dep. Of physiology and pharmacology, Tel Aviv University, Israel
1995-2005, MD, Faculty of Medicine, Tel Aviv University, Israel
Affiliations:
Faculty of Medicine, Tel Aviv University
Research Grants & Awards:
multiple – including ISF, ICRF, Prevent Cancer Foundation, NCI-NIH, Israel Cancer Association, Marsha Rivkin Center, and Maccabi
Publications:
Here are publications of Dr. Keren Levanon
